 Cortexyme, Inc. Nasdaq: CRTX, a clinical stage biopharmaceutical company pioneering potential therapeutics for Alzheimers and other degenerative diseases, today announced Casey Lynch, the companys chief executive officer, chair, and co-founder, will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2 at 2:30 p.m. EDT 11:30 a.m. PDT. 